Skip to content

Analysis of pain and analgesics against oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation

Analysis of pain and analgesics against oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation - Oral pain assessment in pediatric patients undergoing hematopoietic stem cell transplantation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000031143
Enrollment
30
Registered
2020-04-01
Start date
2014-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hematopoietic stem cell transplantation in pediatric patients

Interventions

None listed

Sponsors

Kyoto Prefectural University of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Pediatric patients receiving hematopoietic stem cell transplantation

Exclusion criteria

Exclusion criteria: history of psychological or neurological disorders, severe obesity (body mass index >35%) cognitive impairment.

Design outcomes

Primary

MeasureTime frame
Frequency and dose of opioids agasint pain due to oral mucositis.

Countries

Japan

Contacts

Public ContactChul Kwon

Kyoto Prefectural University of Medicine Department of Pain Management and Palliative Care Medicine

gon0410@koto.kpu-m.ac.jp075-251-5177

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026